Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 12.56% · OPTIONAL
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTSHOULDER INNOVATIONS, INC.'s latest supported as-filed period reports revenue of $17.2M; gross margin moved 205 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 12.56% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -43.04% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 55.95% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 133.45% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 78.26% · CORE
Level · gp.fundamentals.operating_margin
Raw value -58.43% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -9.6% from the comparable as-filed period.
Gross margin changed +205 basis points from the comparable as-filed period.
Gross profit changed +60.1% from the comparable as-filed period.
Inventory changed +34.2% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
SI · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-363913SEC ↗4Aug 18, 2026Period Aug 14, 20260002070582-26-000005SEC ↗8-KAug 10, 2026Period Aug 10, 20260001699350-26-000054SEC ↗4Aug 7, 2026Period Aug 5, 20260001193125-26-340260SEC ↗10-QAug 6, 2026Period Jun 30, 20260001699350-26-000052SEC ↗8-KAug 6, 2026Period Aug 6, 20260001699350-26-000050SEC ↗4Aug 5, 2026Period Aug 3, 20260001193125-26-335278SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 24, 2026Filed Aug 24, 2026 | Gilde Healthcare Holding B.V.Reporting owner | Open Market SaleIndirect | 681 | $23 | $15,404 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 24, 2026 | Gilde Healthcare Holding B.V.Reporting owner | Open Market SaleIndirect | 20,516 | $23 | $463,867 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 24, 2026 | Gilde Healthcare Holding B.V.Reporting owner | Open Market SaleIndirect | 3,900 | $23 | $88,140 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 19.74% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 6.29% · OPTIONAL
Net income changed +47.1% from the comparable as-filed period.
Operating income changed -71.2% from the comparable as-filed period.
Operating margin changed -521 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-330846